Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$547.82 +0.79 (+0.14%)
As of: Nov 12, 2026 · 10:38 AM EST

Vertex Pharmaceuticals (VRTX) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

Vertex Pharmaceuticals (VRTX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 32.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 32.74 Bn
Jun 30, 2026 27.42 Bn
Mar 31, 2026 26.48 Bn
Dec 31, 2025 25.64 Bn
Sep 30, 2025 24.86 Bn
Jun 30, 2025 24.04 Bn
Mar 31, 2025 22.88 Bn
Dec 31, 2024 22.53 Bn
Sep 30, 2024 22.24 Bn
Jun 30, 2024 20.13 Bn
Mar 31, 2024 23.92 Bn
Dec 31, 2023 22.73 Bn
Sep 30, 2023 21.73 Bn
Jun 30, 2023 20.35 Bn
Mar 31, 2023 18.97 Bn
Dec 31, 2022 18.15 Bn
Sep 30, 2022 16.71 Bn
Jun 30, 2022 15.58 Bn
Mar 31, 2022 14.26 Bn
Dec 31, 2021 13.43 Bn
API Access

Vertex Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEY